❌

Reading view

There are new articles available, click to refresh the page.

Pennsylvania Medicaid Spent $297.8M on GLP-1s for Obesity Over the Past 12 Months

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costsβ€”often exceeding $1,000 per monthβ€”put them out of reach for many Americans whose insurance does not cover these medications. A new analysis from…

Pennsylvania's education landscape in 2024

(The Center Square) – Students, parents, and teachers are anxiously watching and waiting to see how the state’s billion-dollar education funding increase and new adequacy formula will impact struggling school districts, even as district property taxes continue to rise.
❌